DocGo Inc. Earnings Per Share (Basic)
DocGo Inc. (DCGO) reported Earnings Per Share (Basic) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-17
- DocGo Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.16.
- DocGo Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.15.
- DocGo Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.28, a 660.00% decline year-over-year.
- DocGo Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.11, a 283.33% decline year-over-year.
- DocGo Inc. earnings per share, basic for fiscal 2025 was -$1.84, a 1020.00% decline from fiscal 2024.
- DocGo Inc. earnings per share, basic for fiscal 2024 was $0.20, a 185.71% increase from fiscal 2023.
- DocGo Inc. earnings per share, basic for fiscal 2023 was $0.07, a 79.41% decline from fiscal 2022.
- DocGo Inc. earnings per share, basic for fiscal 2022 was $0.34, a 13.33% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-17 | -$0.31 10-Q · filed 2026-08-17 | ||
| 2026-03-31 | -$0.15 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$1.84 10-K · filed 2026-03-16 | |||
| 2025-09-30 | -$0.28 10-Q · filed 2025-11-10 | -$0.49 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$0.11 10-Q · filed 2026-08-17 | -$0.21 10-Q · filed 2026-08-17 | ||
| 2025-03-31 | -$0.09 10-Q · filed 2026-05-11 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-05-11 |
| 2024-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.02 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.09 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.20 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.05 10-Q · filed 2025-11-10 | $0.12 derived: net income ÷ weighted average shares · filed 2025-11-10 | $0.23 10-Q · filed 2025-11-10 | $0.30 derived: net income ÷ weighted average shares · filed 2026-03-16 |
| 2024-06-30 | $0.06 10-Q · filed 2025-08-07 | $0.17 10-Q · filed 2025-08-07 | $0.25 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.29 derived: net income ÷ weighted average shares · filed 2026-03-16 |
| 2024-03-31 | $0.11 10-Q · filed 2025-05-08 | $0.18 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.23 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.21 derived: net income ÷ weighted average shares · filed 2026-03-16 |
| 2023-12-31 | $0.07 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.12 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.10 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.07 10-K · filed 2026-03-16 |
| 2023-09-30 | $0.05 10-Q · filed 2024-11-07 | $0.03 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.01 10-Q · filed 2024-11-07 | $0.07 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-06-30 | -$0.02 10-Q · filed 2024-08-07 | -$0.05 10-Q · filed 2024-08-07 | $0.03 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.06 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-03-31 | -$0.03 10-Q · filed 2024-05-08 | $0.04 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.08 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.20 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2022-12-31 | $0.08 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.11 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.24 derived: net income ÷ weighted average shares · filed 2025-02-27 | $0.34 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.03 10-Q · filed 2023-11-06 | $0.16 derived: net income ÷ weighted average shares · filed 2023-11-06 | $0.26 10-Q · filed 2023-11-06 | $0.45 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-06-30 | $0.13 10-Q · filed 2023-08-08 | $0.23 10-Q · filed 2023-08-08 | $0.41 derived: net income ÷ weighted average shares · filed 2024-02-28 | $0.50 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-03-31 | $0.11 10-Q · filed 2023-05-09 | $0.28 derived: net income ÷ weighted average shares · filed 2024-02-28 | $0.37 derived: net income ÷ weighted average shares · filed 2024-02-28 | $0.47 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2021-12-31 | $0.16 derived: net income ÷ weighted average shares · filed 2024-02-28 | $0.26 derived: net income ÷ weighted average shares · filed 2024-02-28 | $0.37 derived: net income ÷ weighted average shares · filed 2024-02-28 | $0.30 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.06 10-Q · filed 2022-11-08 | $0.06 derived: net income ÷ weighted average shares · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$18.19 10-Q · filed 2022-08-09 | -$36.73 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.03 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$0.25 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |